Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | IDO1 | P14902 | 2/20 | 0.52 |
| ▸ | EP300 | Q09472 | 2/20 | 0.52 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.52 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.52 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.46 |
| ▸ | NEK2 | P51955 | 1/20 | 0.46 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.46 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.46 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.46 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.44 |
| ▸ | CRHBP | P24387 | 1/20 | 0.43 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31178708 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| Hydrochloric Acid SCHEMBL6155796 | 0.97 | ALDH1A1 (0.50) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| Chlorobenzene SCHEMBL8843335 | 0.89 | TSHR (0.46) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL1991031 | 0.84 | ALDH1A1 (0.68) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL29914126 | 0.84 | ALDH1A1 (0.68) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL201893 | 0.83 | ALDH1A1 (0.73) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL6562728 | 0.83 | HPRT1 (0.46) | ALDH1A1HPGDTSHRHSD17B10TDP1 | |
| SCHEMBL30366540 | 0.83 | HPRT1 (0.46) | ALDH1A1HPGDTSHRHSD17B10TDP1 | |
| SCHEMBL29404342 | 0.83 | ALDH1A1 (0.73) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| Hydrochloric Acid SCHEMBL7191297 | 0.80 | CYP3A4 (0.69) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114891198-B | Preparation method of polyfluorophenyl ester polymer with low dielectric loss | 西安交通大学 | 2024-06-18 | — | — | CN | claimed |
| CN-114773586-B | Poly (fluorobenzene ester) polymer material and synthetic method thereof | 西安交通大学 | 2024-06-14 | — | — | CN | claimed |
| CN-115368292-A | Benzoindole compound and synthetic method thereof | 陕西科技大学 | 2022-11-22 | — | — | CN | claimed |
| CN-114891199-A | Preparation method of poly (fluorophenyl ester) polymer with high dielectric constant | 西安交通大学 | 2022-08-12 | — | — | CN | claimed |
| CN-114773586-A | Poly (fluorophenyl ester) polymer material and synthesis method thereof | 西安交通大学 | 2022-07-22 | — | — | CN | claimed |
| US-20260062412-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITY | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-4647424-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITY | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-11-12 | — | — | EP | disclosed |
| CN-120484552-B | Corrosion-resistant coating-based aluminum alloy composite material and preparation method thereof | 芯航同方科技(江苏)有限公司 | 2025-09-12 | — | — | CN | disclosed |
| CN-120484552-A | Corrosion-resistant coating-based aluminum alloy composite material and preparation method thereof | 芯航同方科技(江苏)有限公司 | 2025-08-15 | — | — | CN | disclosed |
| US-20240208912-A1 | MTA-Cooperative PRMT5 Inhibitors | MIRATI THERAPEUTICS INC (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240208912-A1 | MTA-Cooperative PRMT5 Inhibitors | MIRATI THERAPEUTICS INC (US) | 2024-06-27 | — | — | US | disclosed |
| CN-114891199-B | Preparation method of polyfluorophenyl ester polymer with high dielectric constant | 西安交通大学 | 2024-06-25 | — | — | CN | disclosed |
| US-5652269-A | MODULATION OF NEUROTRANSMITTER RELEASE, NEUROPROTECTIVE | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1997-07-29 | — | — | US | disclosed |
| US-5637623-A | CENTRAL NERVOUS SYSTEM DISORDERS | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1997-06-10 | — | — | US | disclosed |
| US-5622968-A | ADMINISTERING TO BLOCK VOLTAGE SENSITIVE CALCIUM CHANNELS OF MAMMALIAN NEURONAL CELLS | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1997-04-22 | — | — | US | disclosed |
| US-5614630-A | NEUROTRANSMITTER RELEASE MODULATOR | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1997-03-25 | — | — | US | disclosed |
| US-5403861-A | Treating or preventing nerve cell death | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1995-04-04 | — | — | US | disclosed |
| EP-0584088-A4 | SUBSTITUTED GUANIDINES AND DERIVATIVES THEREOF AS MODULATORS OF NEUROTRANSMITTER RELEASE AND NOVEL METHODOLOGY FOR IDENTIFYING NEUROTRANSMITTER RELEASE BLOCKERS. | CAMBRIDGE NEUROSCIENCE RES (US) | 1995-01-18 | — | — | EP | disclosed |
| EP-0584088-A1 | SUBSTITUTED GUANIDINES AND DERIVATIVES THEREOF AS MODULATORS OF NEUROTRANSMITTER RELEASE AND NOVEL METHODOLOGY FOR IDENTIFYING NEUROTRANSMITTER RELEASE BLOCKERS | CAMBRIDGE NEUROSCIENCE RESEARCH, INC. (US) | 1994-03-02 | — | — | EP | disclosed |
| WO-1992014697-A1 | SUBSTITUTED GUANIDINES AND DERIVATIVES THEREOF AS MODULATORS OF NEUROTRANSMITTER RELEASE AND NOVEL METHODOLOGY FOR IDENTIFYING NEUROTRANSMITTER RELEASE BLOCKERS | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1992-09-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062412-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITY | MYT1, NTMT1, MYL6 | ALDH1A1 2880/4885CYP3A4 1957/4885HPGD 2650/4885 |
| US-20240208912-A1 | MTA-Cooperative PRMT5 Inhibitors | PRMT1, PRMT5, PRMT6 | ALDH1A1 3367/4885CYP3A4 4229/4885HPGD 3263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.